In contrast, serum IgM-free apoptosis inhibitor of macrophage (AIM) is a useful biomarker of NASH-HCC, irrespective of AFP or DCP status [11]. This evidence concerns the gene ACE and metabolic dysfunction-associated steatohepatitis.